Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

CMS doubles down on troubling decision to limit coverage of Alzheimer’s drugs
Share
Bio.News  •  February 24, 2023
CMS reaffirms its decision on coverage of breakthrough Alzheimer’s drugs—here’s what they said. Plus, we popped into USDA’s Agricultural Outlook Forum yesterday where we heard Secretary Vilsack’s views on SAF and what the administration’s thinking about Mexico. (539 words, 2 minutes, 41 seconds)
Read More

What should the Farm Bill include?
Share
Bio.News  •  February 23, 2023
With the Farm Bill up for reauthorization this year, a food, agriculture, and biotech industry coalition (including BIO) released policy recommendations. Plus, we look at what’s happening with the biosimilars market in 2023. (579 words, 2 minutes, 53 seconds)
Read More

COVID boosters work – now, let’s tackle long COVID
Share
Bio.News  •  February 22, 2023
There has been more positive COVID news in recent weeks about the impact of boosters and therapeutics—but we still have work to do on long COVID. (558 words, 2 minutes, 47 seconds)
Read More

Long COVID Virtual Event: Part 1 of 3
Share
Webinars  •  February 22, 2023
This is the first meeting in a series of conferences cohosted by the Biotechnology Innovation Organization (BIO) and Solve M.E. that are designed to foster a private-public engagement and create an R&D roadmap for diagnostics and treatments for Long COVID and Post-infection Diseases. Objective: Convene stakeholders to advance R&D to diagnose and treat Long COVID and post-infection diseases to: --Increase awareness among drug developers to the unmet need and business opportunity in these indications --Establish a knowledge base of emerging research in Long COVID and existing body of data in other post-infection diseases (such as dysautonomia, myalgic encephalomyelitis/ chronic fatigue syndrome, mast cell activation, and others). --Highlight potential biological targets for therapeutic and preventative approaches --Engage experts and regulators to inform design of clinical studies --Establish a pre-competitive collaborative network Recorded on February 21, 2023. Part 1 of 3.
Read More
Long COVID title slide

Long COVID Virtual Event: Part 2 of 3
Share
Webinars  •  February 22, 2023
This is the first meeting in a series of conferences cohosted by the Biotechnology Innovation Organization (BIO) and Solve M.E. that are designed to foster a private-public engagement and create an R&D roadmap for diagnostics and treatments for Long COVID and Post-infection Diseases. Objective: Convene stakeholders to advance R&D to diagnose and treat Long COVID and post-infection diseases to: --Increase awareness among drug developers to the unmet need and business opportunity in these indications --Establish a knowledge base of emerging research in Long COVID and existing body of data in other post-infection diseases (such as dysautonomia, myalgic encephalomyelitis/ chronic fatigue syndrome, mast cell activation, and others). --Highlight potential biological targets for therapeutic and preventative approaches --Engage experts and regulators to inform design of clinical studies --Establish a pre-competitive collaborative network Recorded on February 21, 2023. Part 2 of 3.
Read More
Long COVID title slide

Long COVID Virtual Event: Part 3 of 3
Share
Webinars  •  February 22, 2023
This is the first meeting in a series of conferences cohosted by the Biotechnology Innovation Organization (BIO) and Solve M.E. that are designed to foster a private-public engagement and create an R&D roadmap for diagnostics and treatments for Long COVID and Post-infection Diseases. Objective: Convene stakeholders to advance R&D to diagnose and treat Long COVID and post-infection diseases to: --Increase awareness among drug developers to the unmet need and business opportunity in these indications --Establish a knowledge base of emerging research in Long COVID and existing body of data in other post-infection diseases (such as dysautonomia, myalgic encephalomyelitis/ chronic fatigue syndrome, mast cell activation, and others). --Highlight potential biological targets for therapeutic and preventative approaches --Engage experts and regulators to inform design of clinical studies --Establish a pre-competitive collaborative network Recorded on February 21, 2023. Part 3 of 3.
Read More
Long COVID title slide

New Film Series Highlights the Role of Biotech in Saving Lives and the Planet
Share
Press Release  •  February 21, 2023
The 29-part film takes audiences to the heart of era-defining biotechnology The Biotechnology Innovation Organization (BIO), today launched a 29-part film series, “Nature’s Building Blocks,” spotlighting the role of biotechnology in transforming both our health and the planet as well as addressing global inequalities. BIO’s second original film series, produced by BBC StoryWorks Commercial Productions, uncovers advances in biotechnology that could define this era through three distinct chapters focusing on the environment and sustainability, the health of humanity and the accessibility of health advancements. “Nature’s Building Blocks will transport audiences around the world, showcasing life-altering technology. From tackling the climate crisis to spotlighting the need for more diversity in clinical trials, the audience will learn how biotechnology is harnessing the power of possibility and breaking down barriers,” said Hilary Stiss, Director of International Affairs for BIO. The series explores how biotechnology is being used to feed our growing population, fuel our world, and transform our industries. Through impactful stories, it uncovers innovative technologies defining today’s medicine and explores how conditions such as diabetes, cancer and Parkinson’s disease are being understood and addressed through more sophisticated research and development. From spotlighting women’s health to emphasizing the importance of accessibility of treatments in previously overlooked communities, this series unveils the progressive present and future of biotechnology. “The work of biotechnology is more than just vaccines and medications, it’s defining today's medicine and transforming the way we feed and fuel our world,” said Stiss. The series will be available online for one year. Click here to learn more about “Nature’s Building Blocks.”
Read More

First GM trees planted in a U.S. forest are designed to devour carbon
Share
Bio.News  •  February 21, 2023
Back to work with exciting news about biotech trees and insights into how Medicare may choose the first ten drugs for price controls—plus, a Bio.News exclusive about how we can advance R&D in women’s health. (735 words, 3 minutes, 40 seconds)
Read More

This bill would bring more transparency to PBMs
Share
Bio.News  •  February 17, 2023
Happy Friday. We recap yesterday’s hearing on the Pharmacy Benefit Manager Transparency Act and what BIO says about it—and look at why 2023 could be the year of RSV (in a good way). (610 words, 3 minutes, 3 seconds)Good Day BIO will take a break on Monday, February 20 for Presidents’ Day. We’ll return to our regular publishing schedule on Tuesday, February 21. In the meantime, keep an eye on Bio.News for breaking news.
Read More

Medical Alley Association
Share
BIO Business Solutions - Member Association
Through its partnership with BIO, the Medical Alley Association offers its members the opportunity to take advantage of the BIO Business Solutions® programs listed below. Click on the company name to learn more. There is no fee for Medical Alley members to participate.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 118
  • 119
  • 120
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO